Silver Book Fact

The annual burden to the U.S. economy of age-related macular degeneration (AMD), cataract, diabetic retinopathy, glaucoma, refractive errors, visual impairment, and blindness in adults age 40 and older is estimated at $35.4 billion– $16.2 billion in direct medical costs, $11.1 billion in other direct costs, and $8 billion in lost productivity.

Rein D, Zhang P, Wirth K, Lee P, et al. The Economic Burden of Major Adult Visual Disorders in the United States. Arch Opthalmol. 2006; 124(12): 1754-60. http://archopht.ama-assn.org/cgi/content/abstract/124/12/1754

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Arch Opthalmol
Publication Date
2006
Authors
Rein D, Zhang P, Wirth K, Lee P, et al
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • In a study of new applicants for recent vision loss rehabilitative services, 7% had current major depression and 26.9% met the criteria for subthreshold depression.  
  • The number of cases of visual impairment and blindness from age-related macular degeneration (AMD0 is projected to increase from 620,000 in 2010 to 1.6 million in 2050–assuming no treatments.  
  • Global DR Prevalence
    The overall prevalence of global DR is 34.6%—6.96% for PDR, 6.81% for DME, and 10.2% for vision-threatening DR.  
  • An estimated 424,801 more visually impaired and blind individuals live in nursing homes than would be expected if they had normal vision.  
  • In one study of patients age 48 and older, 17% of the women and 11.1% of the men had dry eye.